Ilex Medical Ltd (TLV:ILX)

Market Cap	680.80M
Revenue (ttm)	920.37M
Net Income (ttm)	38.98M
Shares Out	11.19M
EPS (ttm)	3.48
PE Ratio	14.90
Forward PE	n/a
Dividend	1.22 (2.00%)
Ex-Dividend Date	Apr 7, 2025

Volume	243
Average Volume	4,327
Open	6,085.00
Previous Close	6,085.00
Day's Range	6,085.00 - 6,181.00
52-Week Range	5,643.00 - 8,499.00
Beta	0.02
RSI	48.59
Earnings Date	May 27, 2025

About Ilex Medical

Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology, immunoserology, chemi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1977
• Employees: 178
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ILX

Financial Performance

In 2024, Ilex Medical's revenue was 920.37 million, an increase of 0.45% compared to the previous year's 916.25 million. Earnings were 38.98 million, a decrease of -23.39%.